ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsReferencesView all Images (2)
Glycogen storage disease type 2
Print
Other Resources UpToDate PubMed

Glycogen storage disease type 2

Print Images (2)
Contributors: Marilyn Augustine MD
Other Resources UpToDate PubMed

Synopsis

Glycogen storage disease type 2 (Pompe disease) is an autosomal recessive disorder resulting in acid alpha-glucosidase enzyme deficiency. This causes the buildup of glycogen inside the lysosomes of all tissues, especially within muscle tissue. It is classified as both a glycogen storage disease and a lysosomal storage disease. The causal mutation is found on gene GAA. The disease may first appear in infancy or in later life. Infantile onset occurs within the first few months of life and common findings include hypotonia, cardiomyopathy, cardiomegaly, poor feeding, failure to thrive, and hepatomegaly. Patients with later onset primarily present with skeletal myopathy, weakness, dyspnea, orthopnea, and respiratory failure.

Creatine kinase is elevated in both presentations. Treatment is enzyme replacement therapy.

For more information, see OMIM.

Codes

ICD10CM:
E74.00 – Glycogen storage disease, unspecified

SNOMEDCT:
274864009  – Glycogen storage disease, type II

Differential Diagnosis & Pitfalls

Infantile:
Later onset:

Best Tests

Subscription Required

References

Subscription Required

Last Updated: 10/16/2017
Copyright © 2019 VisualDx®. All rights reserved.
Glycogen storage disease type 2
Print 2 Images
View all Images (2)
(with subscription)
Glycogen storage disease type 2 (Late Onset) : Exertional dyspnea, Proximal muscle weakness, Creatine kinase elevated, Dysphagia, Lower extremity weakness, Orthopnea
Copyright © 2019 VisualDx®. All rights reserved.